Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
IRhythm

iRhythm (NASDAQ: IRTC) insider transactions

In the twelve months to 10 November 2026, executives and directors of iRhythm reported 58 open-market sales of 187,896 shares ($24.5m) and 1 open-market purchase of 5,312 shares ($56,892), by 12 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in iRhythm shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
2 September 2026Wilson Daniel G.Chief Financial OfficerOpen-market sale−773$121.8334,887Form 4
10 August 2026Blackford Quentin S.President and CEOOpen-market sale−26,859$124.65226,008Form 4
10 August 2026Murphy Patrick MichaelCBO and CLOOpen-market sale−7,093$124.6569,699Form 4
10 August 2026Patterson ChadChief Comm & Product OfficerOpen-market sale−7,093$124.6562,125Form 4
10 August 2026Shrishrimal SumiEVP, Chief Risk OfficerOpen-market sale−5,372$124.6544,621Form 4
10 August 2026Turakhia MinangChief Med/sci Ofcr EVP AdvtechOpen-market sale−7,093$124.6560,116Form 4
7 August 2026Blackford Quentin S.President and CEOGrant or award+48,534—252,867Form 4
7 August 2026Murphy Patrick MichaelCBO and CLOGrant or award+13,589—76,792Form 4
7 August 2026Patterson ChadChief Comm & Product OfficerGrant or award+13,589—69,218Form 4
7 August 2026Shrishrimal SumiEVP, Chief Risk OfficerGrant or award+9,706—49,993Form 4
7 August 2026Turakhia MinangChief Med/sci Ofcr EVP AdvtechGrant or award+13,589—67,209Form 4
3 August 2026Patterson ChadChief Comm & Product OfficerOpen-market sale−2,712$122.1255,629Form 4
3 August 2026Smith MervinEVP Strategic Business OpsOpen-market sale−617$122.1222,410Form 4
3 August 2026Rodda JulianneEVP, Chief People OfficerOpen-market sale−2,112$122.1218,201Form 4
2 July 2026Turakhia MinangChief Med/sci Ofcr EVP AdvtechOpen-market sale−1,423$124.7153,620Form 4
2 July 2026Freeman Sean ClintonEVP, Strategy & Corp DevtOpen-market sale−918$124.7113,641Form 4
2 June 2026Shrishrimal SumiEVP, Chief Risk OfficerOpen-market sale−1,716$108.1940,287Form 4
2 June 2026Rosenbaum Marc WadeChief Accounting OfficerOpen-market sale−729$108.1916,155Form 4
29 May 2026Shrishrimal SumiEVP, Chief Risk OfficerGrant or award+133$96.8242,003Form 4
29 May 2026Rosenbaum Marc WadeChief Accounting OfficerGrant or award+178$96.8216,884Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the iRhythm page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.